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Abstract The ARG-11 gene in Saccharomyces cerevisiae 
encodes a protein with the characteristic features of a family of 
35 related membrane proteins that are encoded in the fungal 
genome. Some of them are known to transport various substrates 
and products across the inner membranes of mitochondria, but 
the functions of 29 members of the family are unknown. The 
yeast ARG-11 protein has been over-produced as inclusion bodies 
in Escherichia coli. It has been solubilized in the presence of 
sarkosyl, re-constituted into liposomes and shown to transport 
ornithine in exchange for protons. Its main physiological role is 
probably to take ornithine synthesized from glutamate in the 
mitochondrial matrix to the cytosol where it is converted to 
arginine. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The biosynthesis of arginine in Saccharomyces cerevisiae 
involves five enzymes in the matrix of mitochondria that pro-
duce ornithine from imported glutamate, and three enzymes 
in the cytosol that convert ornithine exported from the mito-
chondrion into arginine [1]. How are the mitochondrial and 
cytosolic segments of this pathway linked together? Yeast 
cells with mutat ions in the ARG-11 gene grow poorly in the 
absence of arginine [2], and in one mutant , MG409 (Argl l -1) , 
the glutamate pool was increased and the arginine and orni-
thine pools were decreased [3]. Therefore, it has been pro-
posed that the protein encoded by ARG-11 provides one 
link between the intra-mitochondrial and cytosolic parts of 
the arginine biosynthetic pathway, either by importing gluta-
mate into the organelle, or by exporting ornithine from the 
mitochondrion into the cytosol [2]. From the genomic se-
quence of Saccharomyces cerevisiae, it is now known that 
ARG-11 is on chromosome XV, and that the gene encodes 
a protein with a sequence containing the characteristic fea-
tures of a family of intrinsic membrane proteins that are in-
volved in the transport of substrates and products across the 
inner membranes of mitochondria [4-6]. Thirty-five members 
of this family have been identified in the genomic sequence of 
Saccharomyces cerevisiae [7]. They include three isoforms of 
the A D P / A T P translocase [8-10], and the transport proteins 
for phosphate [11], citrate [12] and dicarboxylates [7,13], but 
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the functions of the other members of the family are un-
known. 
As described below, the protein encoded by ARG-11 has 
been over-produced and reconstituted by a procedure origi-
nally described for the bacterial over-production and func-
tional reconstitution of the oxoglutarate-malate carrier pro-
tein from bovine mitochondria [14], and employed 
subsequently for the over-production and reconstitution of 
the phosphate [11], citrate [12] and dicarboxylate [7,13] car-
riers from yeast mitochondria. It has been shown by study of 
its t ransport characteristics to be an ornithine carrierer. It 
t ransports arginine and lysine less efficiently than ornithine, 
but citrulline is not transported. 
2. Materials and methods 
2.1. Amplification of the ARG-11 gene from yeast genomic DNA 
Oligonucleotide primers were synthesised with the sequences at the 
extremities of the coding sequence of ARG-11 (nucleotides 570803-
569925 on the negative strand of chromosome XV; Genebank acces-
sion numbers X90518, X94335), with additional Ndel and £coRI sites, 
respectively. The sequence of interest was amplified from S. cerevisiae 
genomic DNA, cloned into the expression vector pMW172 and trans-
formed into E. coli DH5a cells as described before [7], Transformants 
selected on 2XTY plates containing ampicillin (100 ug/ml) were 
screened by direct colony PCR and by restriction digestion of purified 
plasmid DNA. The sequence of ARG-11 was verified by the modified 
dideoxy chain termination method [15]. 
2.2. Bacterial expression and functional reconstitution of the ARG-11 
protein 
The over-production of the protein as inclusion bodies in the bac-
terial cytosol was accomplished as described before for the bovine 
oxoglutarate-malate [14] and yeast dicarboxylate [7] carriers, except 
that the host cells were E. coli C0214(DE3), a mutant of E. coli 
C41(DE3) selected for its ability to over-express the phosphate carrier 
protein without toxic effects (G. Fiermonte and J.E.W., unpublished 
work) as described for the selection of the host strains E. coli 
C41(DE3) and C43(DE3) [16]. Inclusion bodies were purified, and 
the protein solubilised and reconstituted into liposomes in the pres-
ence of substrates, as described previously [7,14]. 
2.3. Protein chemical characterization of the over-expressed protein 
Purified inclusion bodies were analyzed by SDS-PAGE in 17.5% 
gels [14]. The protein was either stained with Coomassie blue dye or 
transferred to poly(vinylidene difluoride) membranes, stained with 
Coomassie blue dye, and its N-terminal sequence determined. The 
yield of purified yeast protein per litre of bacterial culture was esti-
mated as before [7]. 
2.4. Activity assays 
External substrate was removed from proteoliposomes on a Sepha-
dex G-75 column in the presence of a reversible inhibitor of efflux, 
5 uM p-chloro-mercuri-benzene sulphonate. Transport was started by 
adding 5 mM dithioerythritol (DTE) and [3H]ornithine or [14C]lysine 
(from NEM Life Science Products, Milan, Italy) and was terminated 
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pies, the inhibitor and the radiolabelled substrate were added at the 
beginning. For efflux measurements, the proteoliposomes containing 
20 mM ornithine were prelabelled by carrier-mediated exchange equil-
ibration [17] and efflux started by adding 5 mM DTE and stopped by 
the mixture of pyridoxal 5'-phosphate and bathophenanthroline. Ex-
ternal substrate was removed and the internal radioactivity was meas-
ured [17]. In uptake experiments, the experimental values were cor-
rected by subtracting the control value. In efflux experiments, the rate 
in —Adpm/min was obtained from the decrease of internal radioactiv-
ity from a single-exponential decay equation. Transport of other sub-
strates by the reconstituted yeast ARG-11 protein was assayed sim-
ilarly. 
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3. Results and discussion 
3.1. Bacterial expression of the ARG-11 protein 
The ARG-11 protein over-expressed in E. coli C0214(DE3) 
(see Fig. 1, lane 2) had an apparent molecular mass of about 
32 k D a (the calculated molecular mass including the initiator 
methionine is 31580). It was not detected in bacteria har-
vested immediately before induction of expression (not 
shown) nor in cells harvested after induction but lacking the 
ARG-11 coding sequence in the expression vector (lane 1). 
The N-terminal sequence of the protein, M E D S K K K G L I E G , 
was identical to the predicted sequence. The protein accumu-
lated in the bacteria as inclusion bodies. About 50 mg of 
purified protein (see Fig. 1, lane 3) were obtained from a 1 litre 
culture. 
Fig. 1. Expression of the yeast ARG-11 gene product in E. coli. 
Proteins were separated by SDS-PAGE and stained with Coomassie 
blue dye. The positions of molecular weight markers are shown on 
the left in kDa. Lanes 1 and 2, E. coli C0214(DE3) containing the 
expression vector without (lane 1) and with (lane 2) the coding se-
quence. Samples were taken 5 h after induction. The same number 
of bacteria was analyzed in each sample. Lane 3, purified ARG-11 
protein (4 ug) from bacteria in lane 2. 
after 40 s (unless indicated otherwise) by addition of 20 mM pyridoxal 
5'-phosphate and 10 mM bathophenanthroline [17]. In control sam-
Table 1 
Transport of ornithine and lysine by the ARG-11 protein: depend-
ence on internal substrate 
3.2. Substrate specificity and inhibitor sensitivity 
The ARG-11 protein catalysed a [3H]ornithine/ornithine ex-
Internal substrate 
None (sucrose present) 
L-Ornithine 
L-Lysine 
L-Arginine 
D-Ornithine 
D-Lysine 
a-Methyl-L-ornithine 
L-Histidine 
L-Citrulline 
L-Glutamate 
L-Threonine 
L-Proline 
L-Glutamine 
2-Oxoglutarate 
Phosphate 
ADP 
Substrate transported 
(umol/5 min per g protein) 
[3H]Ornithine 
59 
864 
630 
760 
553 
475 
346 
52 
50 
26 
52 
61 
35 
69 
43 
55 
[14C]Lysine 
43 
720 
605 
670 
418 
302 
266 
36 
29 
22 
57 
43 
50 
47 
36 
68 
Proteoliposomes containing the ARG-11 protein were pre-loaded in-
ternally with various substrates (concentration 30 mM). Transport 
was started by addition of 5 mM DTE and 0.05 mM [3H]ornithine 
or 0.5 mM [14C]lysine, and stopped after 5 min. Similar results were 
obtained in 3 different experiments. 
1/[S] ( mM ) 
Fig. 2. Dependence of the rate of ornithine/ornithine exchange in re-
constituted liposomes on the external ornithine concentration and 
competitive inhibition by arginine and lysine. [3H]Ornithine and 
5 mM DTE were added to proteoliposomes containing 20 mM orni-
thine. Except in the controls (o), 1 mM lysine (•) or 1 mM argi-
nine (□) was added simultaneously with the [3H]ornithine. 
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change, which was inhibited by />-hydroxy-mercuri-benzoate, 
a known inhibitor of the ornithine carrier purified from rat 
liver mitochondria [18], but not the homo-exchanges of phos-
phate, pyruvate, malate, oxoglutarate, citrate, glutamate, as-
partate, adenosine diphosphate, carnitine and glutamine (ex-
ternal concentrations 0.5 mM, transport 10 min reaction). No 
such activity was found by reconstitution of sarkosyl-solubi-
lised inclusion bodies from bacterial cells either lacking the 
expression vector for ARG-11, or harvested immediately be-
fore induction of over-expression. 
The substrate specificity of the ARG-11 protein was inves-
tigated by measuring the uptake of [3H]ornithine and of 
[14C]lysine into proteoliposomes which had been pre-loaded 
with a variety of substrates (see Table 1). The highest activ-
ities were observed in the presence of internal ornithine, argi-
nine and lysine. There was also significant activity with D-
ornithine and D-lysine, and a-methyl-L-ornithine, but not 
with internal histidine or citrulline. The residual values with 
internal glutamate, threonine, proline, glutamine, oxogluta-
rate, phosphate, ADP, and (not shown) alanine, leucine, as-
partate and malate were approximately the same as the value 
with internal sucrose. Therefore, the substrate specificity of 
the ARG-11 protein is confined to a narrow range of basic 
amino acids, and is similar to that of the rat ornithine carrier 
[18], except that citrulline is not transported by the yeast pro-
tein. 
Ornithine transport by the ARG-11 protein was inhibited 
by sulphydryl reagents (mersalyl, /vhydroxy-mercuri-benzoate 
and />-chloro-mercuri-benzene sulphonate at 5 uM, 7V-ethyl-
maleimide and eosin 5-maleimide at higher concentrations), 
and various cations, that inhibit the rat ornithine carrier 
[18,19], also inhibited the yeast protein (see Table 2). As 
with the rat ornithine carrier, divalent cations were more ef-
fective inhibitors than monovalent cations. The most effective 
cation inhibitor was Pr3+, but its inhibition is probably un-
specific and due to its binding strongly to lipid head groups. 
Carboxyatractyloside, 1,2,3-benzenetricarboxylate, butylmalo-
nate and phthalonate (inhibitors of the ADP/ATP, citrate, 
dicarboxylate and oxoglutarate transporters [20-23], respec-
tively) did not inhibit the ARG-11 protein. 
In addition, the ability of unlabelled potential substrates to 
inhibit the reconstituted [3H]ornithine/ornithine exchange was 
examined. Ornithine, lysine, arginine and, to a lesser extent, 
the D-stereoisomers of the first two amino acids inhibited the 
uptake of radiolabelled ornithine (Table 2), whereas citrulline, 
histidine and (not shown) threonine, glutamate, glutamine, 
phosphate, malate, oxoglutarate and ADP did not. Therefore, 
the substrate specificity and inhibition characteristics of the 
ARG-11 protein are very similar to those of the rat ornithine 
carrier, and they differ only in their behaviour with citrulline 
[18,19]. 
3.3. Kinetic characteristics of the ARG-11 protein 
The Km and Vmax values for ornithine exchange at 25°C, 
from a typical experiment (see Fig. 2), were 0.094 mM and 1.2 
mmol/min per g protein, respectively, and the average values 
from six experiments were 0.11 ±0.01 mM and 1.1 ±0.3 
mmol/min per g protein, respectively. The Km for ornithine 
uptake is close to that of the rat ornithine carrier [19], but the 
Vmax is lower than that of the rat protein (3.2 ± 0.7 mmol/min 
Table 2 
Effect of inhibitors and externally added substrates on the uptake of [3H]ornithine into proteoliposomes containing the ARG-11 protein 
Reagents Ornithine transport 
(umol/min/g protein) 
986 
20 
47 
0 
128 
0 
0 
700 
631 
384 
296 
168 
907 
887 
917 
927 
1060 
32 
509 
233 
572 
773 
1018 
1028 
Inhi 
98 
95 
101 
87 
100 
102 
29 
36 
61 
70 
83 
8 
10 
7 
6 
97 
52 
78 
46 
27 
4 
3 
ibition (%) 
Experiment 1 
None 
./V-Ethylmaleimide 
Eosin 5'-maleimide 
Mersalyl 
p-HMB 
/>-CMBS 
Bathophenanthroline+pyridoxal 5'-phosphate 
Na+ 
K+ 
Ca2+ 
Mg2+ 
pr3+ 
Carboxyatractyloside 
1,2,3-Benzenetricarboxylate 
Butylmalonate 
Phthalonate 
Experiment 2 
None 
L-Ornithine 
L-Lysine 
L-Arginine 
D-Ornithine 
D-Lysine 
L-Histidine 
L-Citrulline 
Proteoliposomes were loaded with 30 mM ornithine and transport was started by adding 0.4 mM [3H]ornithine and 5 mM DTE. The incubation 
time was 1 min. Thiol reagents were added 2 min before the labelled substrate; the other inhibitors and external substrates were added together 
with [3H]ornithine. All inhibitors and substrates were used at a concentration of 8 mM, except for N-ethylmaleimide and eosin 5'-maleimide (1 
mM), organic mercurials (5 uM), cations (added as Cl~ salts at 15 mM), carboxyatractyloside (0.15 mM), bathophenanthroline (10 mM) and 
pyridoxal 5'-phosphate (30 mM). Similar results were obtained in three independent experiments. 
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Fig. 3. Dependence of ornithine uniport on the trans-membrane pH gradient. The reconstitution mixture contained 15 mM Pipes and 15 mM 
Hepes at pH 6.0 (•) or pH 8.0 (O, □, A, A, ♦). After reconstitution of the carrier into liposomes, 30 mM unbuffered sucrose was used to 
equilibrate and to elute the Sephadex G-75 columns. In (A), transport was started by adding mixtures of 5 mM DTE, 0.4 mM [3H]ornithine 
and 15 mM Hepes at pH 8.0. In (B), transport was started by adding ( A ) 15 mM Pipes/15 mM Hepes pH 8.0 and 5 mM DTE, ( A ) 15 mM 
Pipes/15 mM Hepes pH 6.0 and 5 mM DTE, (□) 15 mM Pipes/15 mM Hepes pH 6.0, 5 mM DTE, 30 mM pyridoxal 5'-phosphate and 10 
mM bathophenanthroline, and (♦) 15 mM Pipes/15 mM Hepes pH 8.0, 5 mM DTE and 10 mM ornithine. 
per g protein) [19]. The other two substrates, arginine and 
lysine, inhibited ornithine uptake competitively. The Ki values 
of arginine and lysine for [3H]ornithine uptake were 0.6 ± 0.1 
mM and 1.3 ±0.2 mM, respectively (average of four experi-
ments). The K[ value for lysine is close to that of the rat 
protein [19]. 
3.4. Dependence of ornithine uniport on the transmembrane pH 
gradient 
The influence of intraliposomal pH (at fixed external pH) 
on the uptake of [3H]ornithine as uniport (in the absence of 
internal ornithine) was analyzed. The amount of substrate 
taken up by uniport increased markedly with decreasing in-
ternal pH from 8.0 to 6.0 (see Fig. 3A), whereas the rate of 
ornithine/ornithine exchange (out 0.4 mM; in 20 mM) was 
unaffected (not shown). Therefore, the ARG-11 protein cat-
alyses both ornithine/ornithine and ornithine/H+ exchanges. 
The ornithine/H+ exchange activity was confirmed by meas-
uring the efflux of [3H]ornithine from proteoliposomes. The 
addition of pH 6.0 buffer to proteoliposomes with an internal 
pH of 8.0 induced greater efflux of ornithine than an external 
pH of 8.0, and the efflux was prevented by inhibitors of orni-
thine/ornithine exchange (see Fig. 3B). Over the first 40 min, 
the data fitted a single-exponential decay equation. The trans-
port rates were 103 and 375 dpm/min per g protein for the 
unidirectional efflux at external pH 8.0 and 6.0, respectively, 
and 4970 dpm/min per g protein for the ornithine/ornithine 
exchange. Therefore, the exchange reaction is much faster 
than the uniport, and in this respect, the ARG-11 protein is 
similar to the mitochondrial phosphate and carnitine carriers 
[24,25]. 
3.5. Conclusions 
The main physiological function of the yeast ornithine car-
rier is in the export of ornithine at the expense of the proton 
motive force generated across the mitochondrial membrane by 
electron transport. The inner membranes of rat liver mito-
chondria were suggested to have two transport systems for 
ornithine, one for ornithine (and lysine) flux via an orni-
thine/H+ antiport [26-28], and the second for ornithine im-
port in exchange for citrulline [29]. The ornithine/citrulline 
carrier (purified but not sequenced from rat liver mitochon-
dria [18]) transports lysine, arginine, ornithine and citrulline 
by an electroneutral antiport mechanism [18,19,30]. In addi-
tion to the ornithine/citrulline exchange, the purified protein 
catalyses less efficiently an ornithine/H+ exchange [30]. There-
fore, the mammalian carrier seems to have evolved to accept 
citrulline as substrate, and fulfills the important function of 
exchanging cytosolic ornithine and intramitochondrial citrul-
line, an essential step in the urea cycle. 
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